The stock of Elicio Therapeutics Inc (ELTX) has gone down by -40.43% for the week, with a -36.86% drop in the past month and a -3.88% drop in the past quarter. The volatility ratio for the week is 12.70%, and the volatility levels for the past 30 days are 6.86% for ELTX. The simple moving average for the past 20 days is -36.13% for ELTX’s stock, with a -13.53% simple moving average for the past 200 days.
Is It Worth Investing in Elicio Therapeutics Inc (NASDAQ: ELTX) Right Now?
The 36-month beta value for ELTX is also noteworthy at 0.90. There are mixed opinions on the stock, with 1 analysts rating it as a “buy,” 0 rating it as “overweight,” 1 rating it as “hold,” and 0 rating it as “sell.”
The public float for ELTX is 7.74M, and at present, short sellers hold a 2.20% of that float. The average trading volume of ELTX on April 02, 2025 was 46.17K shares.
ELTX) stock’s latest price update
Elicio Therapeutics Inc (NASDAQ: ELTX)’s stock price has gone decline by -19.64 in comparison to its previous close of 6.16, however, the company has experienced a -40.43% decrease in its stock price over the last five trading days. globenewswire.com reported 2025-03-31 that Completed enrollment of Phase 2 AMPLIFY-7P randomized study; disease-free survival (“DFS”) event-driven interim analysis expected in Q3 2025
ELTX Trading at -38.78% from the 50-Day Moving Average
After a stumble in the market that brought ELTX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -56.77% of loss for the given period.
Volatility was left at 6.86%, however, over the last 30 days, the volatility rate increased by 12.70%, as shares sank -39.49% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -20.80% lower at present.
During the last 5 trading sessions, ELTX fell by -40.43%, which changed the moving average for the period of 200-days by -41.70% in comparison to the 20-day moving average, which settled at $7.75. In addition, Elicio Therapeutics Inc saw -2.94% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for ELTX
Current profitability levels for the company are sitting at:
- -38.58 for the present operating margin
The net margin for Elicio Therapeutics Inc stands at -44.51. The total capital return value is set at -2.7. Equity return is now at value -170157.38, with -187.61 for asset returns.
Based on Elicio Therapeutics Inc (ELTX), the company’s capital structure generated -1.13 points at debt to capital in total, while cash flow to debt ratio is standing at -6.17. The debt to equity ratio resting at -0.53. The interest coverage ratio of the stock is 98.87.
Currently, EBITDA for the company is -44.99 million with net debt to EBITDA at 0.26. When we switch over and look at the enterprise to sales, we see a ratio of 57.38. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.80.
Conclusion
In summary, Elicio Therapeutics Inc (ELTX) has had a bad performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
